Recommendations for the reporting of bone tumors

Human Pathology

Volumn 35, Issue 10, 2004, Pages 1173-1178

  Abdul Karim, Fadi W ^a   Bauer, Thomas W ^b   Kilpatrick, Scott E ^c   Raymond, Kevin A ^d   Siegal, Gene P ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c FORSYTH MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

ACS; ADASP; AJCC; American College of Surgery; American Joint Committee on Cancer; Association of Directors of Anatomic and Surgical Pathology; bone tumors; CAP; COC; College of American Pathologists; Commission on Cancer; neoplasms of bone; orthopaedic tumors

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE MATRIX; BONE RESECTION; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CURETTAGE; EWING SARCOMA; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; LIMB SALVAGE; NEEDLE BIOPSY; NEUROECTODERM TUMOR; ORTHOPEDIC SURGERY; OSTEOSARCOMA; PROGNOSIS; RADIODIAGNOSIS; RADIOLOGIST; REVIEW; STANDARDIZATION; TUMOR NECROSIS;

EID: 5444228909     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.07.004     Document Type: Article

References (21)

1. Ayala A.G., Mackay B., Jaffe N., et al. Osteosarcoma The Pathological Study of Specimens from En Bloc Resection in Patients Receiving Preoperative Chemotherapy. van Eys J., Sullivan M.P. Status of the Curability of Childhood Cancers. 1980;127-144 Raven Press, New York
2. Ayala A.G., Murray J.A., Erling M.A., et al. Osteoid-osteoma Intraoperative tetracycline- fluorescence demonstration of the nidus. J Bone Joint Surg Am. 68:1986;747-771
3. Ayala A.G., Raymond A.K., Jaffe N. The pathologist's role in the diagnosis and treatment of osteosarcoma in children. Hum Pathol. 15:1984;258-266
4. Bridge J.A., Nelson M., McComb E., et al. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature. Cancer Genetics Cytogenet. 95:1997;74-87
5. Davis A.M., Bell R.S., Goodwin P.J. Prognostic factors in osteosarcoma A critical review. J Clin Oncol. 12:1994;423-431
6. de Alava E., Kawai A., Healey J.H., et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol. 164:1998;1248-1255
7. Goorin A.M., Harris M.B., Berstein M., et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma A pediatric oncology group trial. J Clin Oncol. 15:2002;426-433
8. Huvos A.G., Rosen G., Marcove R.C. Primary osteogenic sarcoma Pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 101:1977;14-18
9. Khuu H., Moore D., Young S., et al. Examination of tumor and tumor-like conditions of bone. Annals Diagn Pathol. 3:1999;364-369
10. Kilpatrick S.E., Ward W.G., Chauvenet A.R., et al. The role of fine-needle aspiration biopsy in the initial diagnosis of pediatric bone and soft tissue tumors An institutional experience. Mod Pathol. 11:1998;923-928
11. Koscick R.L., Petersilge C.A., Makley J.T., et al. CT -guided fine needle core biopsy of skeletal lesions. Complementary diagnostic techniques. Acta Cytol. 42:1998;697-702
12. Nicol K.K., Ward W.G., Savage P.D., et al. Fine-needle aspiration biopsy of skeletal versus extraskeletal osteosarcoma. Cancer. 84:1998;176-185
13. Nishida J., Sim F.H., Wenger D.E., et al. Malignant fibrous histiocytoma of bone. A clinicopathologic study of 81 patients. Cancer. 79:1997;482-493
14. Picci P., Bohling T., Bacci G., et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol. 15:1997;1553-1559
15. Provisor A.J., Ettinger L.J., Nachman J.B., et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy A report from the Children's Cancer Group. J Clin Oncol. 15:1997;76-84
16. Raymond A.K., Chawla S.P., Carrasco C.H., et al. Osteosarcoma chemotherapy effect A prognostic factor. Semin Diagn Pathol. 4:1987;212-236
17. Rosen G., Caparros B., Huvos A.G., et al. Preoperative chemotherapy for osteogenic sarcoma Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 49:1982;1221-1230
18. Schajowicz F., Sissons H.A., Sobin L.H. The world health organization's histologic classification of bone tumors. Cancer. 75:1995;1208-1214
19. Urban C., Rosen G., Huvos A.G., et al. Chemotherapy of malignant fibrous histiocytoma of bone. A report of 5 cases. Cancer. 51:1983;795-802
20. Wold L.E. Practical approach to processing osteosarcomas in the surgical pathology laboratory. Pediatr Devel Pathol. 1:1998;449-454
21. Wunder J.S., Paulian G., Huvos A.G., et al. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 80:1998;1020-1033